A “micro-tap” for treating glaucoma

Share via AddThis
Posted March 26, 2013

A tiny, EPFL-designed implantable device that can be positioned within the eye and controlled remotely may well revolutionize the treatment of glaucoma. The device should be through testing this year and on its way to the market in 2014 via Rheon Medical, an EPFL spin-off.

Glaucoma is the second leading cause of blindness globally, after cataracts. It is characterized by the presence of too much liquid between the cornea and the iris. This leads to a build-up of pressure within the eye, a situation that can destroy the optic nerve if it is not handled correctly.

Read more at: EPFL



53,366 science & technology articles

Categories

Our Articles (see all)

General News

Follow us

Facebook   Twitter   Pinterest   StumbleUpon   Plurk
Google+   Tumblr   Delicious   RSS   Newsletter via Email

Featured Video (see all)

The Danish researchteam, CODER, has found out, that the human brain can beat the calculating powers of a computer, when it comes to solving quantum-problems. Image credit: Colourbox
Scientists map brain’s thesaurus to help decode inner thoughts
What if a map of the brain could help us decode people’s inner thoughts? UC Berkeley scientists have taken…

Featured Image (see all)


Experimental therapy for brain cancer could prevent drug resistance
UCLA and Caltech researchers have developed a technique that shows promise for preventing drug resistance in people with…